Triamcinolone Hexacetonide Injection shortage

Currently in Shortage

Triamcinolone Hexacetonide Injection is currently listed as Currently in Shortage in the FDA Drug Shortage Database. Reported reason: Delay in shipping of the drug.

Therapeutic category

Rheumatology

Dosage form

Injection

Routes

INTRA-ARTICULAR

Last updated

09/17/2025

Strength variants

Not specified

Need sourcing help for Triamcinolone Hexacetonide Injection?

Get connected with licensed distributors and 503B compounders that can fulfill orders during active shortages. Verified suppliers, no spam.

Connect with a sourcing partner

Manufacturers reporting shortage

Medexus1-855-336-3322 Option 9
Currently in Shortage

Reason for shortage

Delay in shipping of the drug

Availability: Unavailable

ad slot 300x250

Related shortages in Rheumatology

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/08/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/08/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Demand increase for the drug
Updated: 04/07/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Not specified
Updated: 04/06/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Not specified
Updated: 04/06/2026

Methylprednisolone Acetate Injection

Currently in Shortage

Category: Rheumatology
Reason: Shortage of an active ingredient
Updated: 04/06/2026

This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.